Content about Lipoprotein

February 16, 2012

Study: CholestOff helps reduce LDLs by 5%

A study published in the November 2011 International Journal of Food Sciences and Nutrition demonstrated a nearly 5% reduction in “bad” low-density lipoprotein cholesterol when Pharmavite's CholestOff was added to the National Cholesterol Education Program therapeutic lifestyle changes diet, Pharmavite announced Wednesday.

NORTHRIDGE, Calif. — A study published in the November 2011 International Journal of Food Sciences and Nutrition demonstrated a nearly 5% reduction in “bad” low-density lipoprotein cholesterol when Pharmavite's CholestOff was added to the National Cholesterol Education Program therapeutic lifestyle changes diet, Pharmavite announced Wednesday.

July 22, 2011

Study finds cholesterol drug torcetrapib may help control diabetes

A drug designed to boost high-density lipoprotein cholesterol levels also may improve blood-sugar control for diabetics, according to a new analysis of a discontinued study.

NEW YORK — A drug designed to boost high-density lipoprotein cholesterol levels also may improve blood-sugar control for diabetics, according to a new analysis of a discontinued study.

Australian researchers found that torcetrapib, a cholesteryl ester transfer protein inhibitor, could improve HDL or "good" cholesterol levels while improving blood-sugar control among diabetics.